WO2003007869A3 - Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres - Google Patents
Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres Download PDFInfo
- Publication number
- WO2003007869A3 WO2003007869A3 PCT/BR2002/000099 BR0200099W WO03007869A3 WO 2003007869 A3 WO2003007869 A3 WO 2003007869A3 BR 0200099 W BR0200099 W BR 0200099W WO 03007869 A3 WO03007869 A3 WO 03007869A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adjuvants
- gene
- codifies
- gene vectors
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02744957A EP1420823A2 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
AU2002317056A AU2002317056A1 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
CA002453959A CA2453959A1 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0103887-7A BR0103887C1 (en) | 2001-07-17 | 2001-07-17 | Immunogenic compositions containing biodegradable microspheres encapsulating antigens, gene vectors and adjuvants |
BRPI0103887 | 2001-07-17 | ||
BRC10103887 | 2002-07-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003007869A2 WO2003007869A2 (en) | 2003-01-30 |
WO2003007869A3 true WO2003007869A3 (en) | 2004-03-18 |
Family
ID=3947962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2002/000099 WO2003007869A2 (en) | 2001-07-17 | 2002-07-17 | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1420823A2 (en) |
CN (1) | CN1549728A (en) |
BR (1) | BR0103887C1 (en) |
CA (1) | CA2453959A1 (en) |
WO (1) | WO2003007869A2 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007001448A2 (en) | 2004-11-04 | 2007-01-04 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
CN1317560C (en) * | 2005-10-19 | 2007-05-23 | 华中科技大学 | Method for increasing coding stability of quantum point coding microball |
WO2007070682A2 (en) | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
CA2648099C (en) | 2006-03-31 | 2012-05-29 | The Brigham And Women's Hospital, Inc | System for targeted delivery of therapeutic agents |
CA2652280C (en) | 2006-05-15 | 2014-01-28 | Massachusetts Institute Of Technology | Polymers for functional particles |
WO2007150030A2 (en) | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
EP2134830A2 (en) | 2007-02-09 | 2009-12-23 | Massachusetts Institute of Technology | Oscillating cell culture bioreactor |
WO2008124639A2 (en) | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Poly (amino acid) targeting moieties |
ES2627292T3 (en) | 2007-10-12 | 2017-07-27 | Massachusetts Institute Of Technology | Vaccine Nanotechnology |
CN101376023B (en) * | 2008-10-10 | 2011-12-28 | 山西海森生物制品有限公司 | Vaccine sustained-release agent for birds as well as preparation and inoculation method thereof |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8591905B2 (en) * | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
EP2661253B1 (en) * | 2011-01-04 | 2017-04-19 | Archivel Farma, SL | Liposome formulation suitable for treating or preventing tuberculosis |
EP2802345B1 (en) | 2012-01-12 | 2018-03-07 | Archivel Farma, S.l. | Mtb-c vaccine against allergic responses |
DK2897620T3 (en) | 2012-09-21 | 2020-08-17 | Intensity Therapeutics Inc | CANCER TREATMENT PROCEDURE |
US10549444B2 (en) | 2014-05-14 | 2020-02-04 | Dicar, Inc. | Protective cover including patterned backings |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01207237A (en) * | 1988-02-15 | 1989-08-21 | Sawai Seiyaku Kk | Tumor necrosis factor inducer |
US6048551A (en) * | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
-
2001
- 2001-07-17 BR BR0103887-7A patent/BR0103887C1/en not_active IP Right Cessation
-
2002
- 2002-07-17 CA CA002453959A patent/CA2453959A1/en not_active Abandoned
- 2002-07-17 WO PCT/BR2002/000099 patent/WO2003007869A2/en active Search and Examination
- 2002-07-17 EP EP02744957A patent/EP1420823A2/en not_active Withdrawn
- 2002-07-17 CN CNA028171861A patent/CN1549728A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01207237A (en) * | 1988-02-15 | 1989-08-21 | Sawai Seiyaku Kk | Tumor necrosis factor inducer |
US6048551A (en) * | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 19890821, Derwent World Patents Index; AN 1989-282538 * |
Also Published As
Publication number | Publication date |
---|---|
BR0103887A (en) | 2003-08-05 |
WO2003007869A2 (en) | 2003-01-30 |
EP1420823A2 (en) | 2004-05-26 |
BR0103887C1 (en) | 2005-11-08 |
CN1549728A (en) | 2004-11-24 |
CA2453959A1 (en) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003007869A3 (en) | Immunogenic compositions containing antigens, gene vectors and adjuvants-loaded biodegradable microspheres | |
Nunberg et al. | Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. | |
WO2003011223A3 (en) | Immunomodulatory compounds and methods of use thereof | |
KR970707281A (en) | A polynucleotide tuberculosis vaccine | |
IL144671A0 (en) | Immunological adjuvants compounds compositions and methods of use thereof | |
CA2421683A1 (en) | Microparticles for delivery of the heterologous nucleic acids | |
Magiri et al. | Recent advances in experimental polyphosphazene adjuvants and their mechanisms of action | |
PT1104306E (en) | CPG COMPOSITIONS AND SAPONIN ADJUVANTS AND THEIR METHODS | |
Källenius et al. | Should a new tuberculosis vaccine be administered intranasally? | |
Liu et al. | The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18 | |
CA2523084A1 (en) | Tuberculosis vaccine with improved efficacy | |
CA2391843A1 (en) | Hcv vaccine compositions | |
AU1813701A (en) | Interleukin-1 muteins useful as vaccine adjuvants | |
Rolph et al. | CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes | |
Peacey et al. | Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response | |
Operschall et al. | Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice | |
WO2015138471A1 (en) | Heat inactivated poxvirus improves vaccination results | |
WO2002009752A3 (en) | Immunological adjuvant compounds | |
WO2000006198A3 (en) | Adjuvant comprising pulmonary surfactant | |
Li et al. | The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis | |
WO2001010469A3 (en) | Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines | |
HK1025220A1 (en) | Novel saponin compositions and uses thereof | |
WO2001015727A3 (en) | Compositions of immunostimulatory polymers and saponin adjuvants and uses thereof | |
WO2002004497A3 (en) | Multiple antigenic peptides immunogenic against streptococcus pneumoniae | |
Morais et al. | Efficacy of Chitosan as Vaccine Adjuvant Against Paracoccidioidomycosis in Mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2453959 Country of ref document: CA Ref document number: 87/CHENP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002744957 Country of ref document: EP Ref document number: 200401274 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20028171861 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002744957 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002744957 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |